An equation for tacrolimus daily dose calculation in renal transplant patients – simple and cost saving?

Nemanja Rančić; Zagorka Lozanov-Crvenković; Momir Mikov; Neven Vavić; Viktorija Dragojević-Simić

doi:10.2298/VSP180529126R

Nemanja Rančić Centre for Clinical Pharmacology; Medical Faculty Military Medical Academy, University of Defence
Zagorka Lozanov-Crvenković Department of mathematics and informatics; Faculty of Sciences, University of Novi Sad
Momir Mikov Institute for Pharmacology, Clinical Pharmacology and Toxicology; Medical Faculty, University of Novi Sad
Neven Vavić Clinic for Nephrology, Centre for Transplantation of Solid Organs; Medical Faculty Military Medical Academy, University of Defence
Viktorija Dragojević-Simić Centre for Clinical Pharmacology; Medical Faculty Military Medical Academy, University of Defence

DOI: https://doi.org/10.2298/VSP180529126R

References

REFERENCES

Jankovic SM, Dragojevic-Simic V, Milovanovic DR. Impact of clinical pharmacology on health care: Serbian experi¬ence. Eur J Clin Pharmacol 2005; 61(10): 787–8.

Vavic N, Rancic N, Dragojevic-Simic V, Draskovic-Pavlovic B, Bo-konjic D, Ignjatovic L, et al. The influence of comedi¬cation on tacrolimus blood concentration in patients sub¬jected to kidney transplantation: retrospective study. Eur J Drug Metab Phar-macokinet 2014; 39(4): 243‒53.

Stratta P, Quaglia M, Cena T, Antoniotti R, Fenoglio R, Mene¬gotto A, et al. The interactions of age, sex, body mass index, genet-ics, and steroid weight-based doses on tac¬rolimus dosing re-quirement after adult kidney transplanta¬tion. Eur J Clin Phar-macol 2012; 68(5): 671–80.

Provenzani A, Santeusanio A, Mathis E, Notarbartolo M, Lab-bozzetta M, Poma P, et al. Pharmacogenetic considera¬tions for optimizing tacrolimus dosing in liver and kidney transplant pa-tients. World J Gastroenterol 2013; 19(48): 9156–73.

Vavić N, Rančić N, Cikota-Aleksić B, Magić Z, Cimeša J, Obrenčević K, et al. The distribution of genetic polymor¬phism of CYP3A5, CYP3A4 and ABCB1 in patients sub¬jected to renal transplantation. Vojnosanit Pregl 2016; 73(7): 663–7.

Rančić N, Vavić N, Cikota-Aleksić B, Magić Z, Mikov M, Bok¬onjić D, et al. The relationship between tacrolimus concentration - dose ratio and genetic polymorphism in patients subjected to renal transplantation. Vojnosanit Pregl 2018; 75(2): 147–53.

Rančić NK, Vavić NN, Kovačević AM, Mikov MM, Drago¬jević-Simić VM. Drug-drug interactions of tacrolimus. Hosp Pharmacol 2015; 2(3): 291–6.

Rančić N, Dragojević-Simić V, Vavić N, Kovačević A, Šegrt Z, Drašković-Pavlović B, et al. Tacrolimus concentra¬tion/dose ratio as a therapeutic drug monitoring strategy: the influence of gender and comedication. Vojnosanit Pregl 2015; 72(9): 813–22.

Passey C, Birnbaum AK, Brundage RC, Oetting WS, Israni AK, Ja-cobson PA. Dosing equation for tacrolimus using ge¬netic va-riants and clinical factors. Br J Clin Pharmacol 2011; 72(6): 948–57.

Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, et al. Improved prediction of tacrolimus concen¬trations early after kidney transplantation using theory-based pharmacoki-netic modelling. Br J Clin Pharmacol 2014; 78(3): 509–23.